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L IVER allograft rejection is diagnosed largely base.d on liver function tests indicating graft damage associated 
with rejection. but histopathological diagnosis using biopsy 
is still necessarv. Since it can be difficult to distinguish 
rejection from ~ther causes of graft damage in the absence 
of liver histopathology. detection of a marker for immune 
activation and a mediator of inflammation could provide a 
noninvasive method of diagnosing rejection. 
Several studies have shown that the postoperative course 
of inflammatorv cvtokines such as tumor necrosis factor 
(TNF)-a' is pr~di~tive of rejection after human orthotopic 
liver transplantation. We have also previously shown that 
daily monitoring of serum or plasma interleukin Efi!-~ 
levels can be useful in predicting long-term graft prognosls.-
However. few reports compare cytokine profiles after liver 
transplantation. 
Therefore. in this study. we monitored plasma and serum 
levels of cytokines in five transplant recipients who eventu-
ally lost liver grafts because of relapsing rejection episodes. 
SUBJECTS AND METHODS 
FK 506 or cyclosporine (CyA). to which variable doses of methyl-
prednisolone were added. wcre used in baseline immunosuppres-
sion; OKT3 was given as indicated. Using ELISA. we monitored 
serum levels of IL-2. IL-6. TNF-a. and IL-l{3 in three liver 
transplant recipients and two abdominal organ-cluster transplant 
recipients who had experienced allograft rejection and eventually 
lost their liver allografts. ELISA involved a two-step sandwich 
enzyme immunoassay using Quantikine (Research and Diagnostic 
Systems Inc. Minneapolis. Minn) as described e1sewhere.2 Daily 
monitored cvtokine levels were evaluated and compared to clinical 
courses and ihe histopathological diagnosis of rejection. Serum and 
plasma levels were basically monitored daily around biopsy-proven 
rejection episodes. 
RESULTS 
Serum levels of IL-2. IL-lf3. and TNF-a in 30 healthy 
volunteers were all under detection. However. serum levels of 
IL-6of30heaJthyvolunteerswere 18:!: 34 pglmL (mean :!: SD). 
As shown elsewhere. l serum and plasma levels of IL-6 
decreased after liver transplantation. regardless of pre trans-
plantation values. Patients with infection subsequently de-
veloped continuously high IL-6 levels. In patients without 
infection, significantly higher levels of IL-6 were usually 
found prior to the histopathological diagnosis of rejection. 
(L-6 elevations were spike-shaped, correlated poorly with 
the histological grade of rejection, and were highly respon-
sive to augmented immunosuppression. 
In the five cases of rejection episodes we saw, serum IL-2 
and IL-lf3 levels were not detected during the entire 
monitoring period. The elevations of serum TNF-a levels 
were similar to those for IL-6. Clinical courses and evalu-
ations of serum IL-6 and TNF-a levels in five cases were 
shown as follows. 
Case 1 
A 62-year-old man with alcoholic cirrhosis underwent or-
thotopic liver transplantation (Fig I). His pretransplant 
plasma IL-6 level was high. but it was decreased after liver 
transplantation. The serum total bilirubin (TB) level also 
decreased as liver function improved. Liver biopsy on 
postoperative day (POD) 8 did not show acute cellular 
rejection (ACR). POD 16 to 17, showing that his liver 
function had recovered. Serum TB levels increased on POD 
18, however, which indicate liver dysfunction due to ACR 
or some other cause. Liver biopsy performed on POD 19 
showed moderate ACR. Soon after the diagnosis, intrave-
nous administration of methylprednisolone (1 g x 5) was 
given. ACR was partially responsive to augmented immu-
nosuppressive therapy, the graft was eventually lost. Con-
cerning serum inflammatory cytokine profiles, spike-shaped 
elevation of IL-6 (>100 pglmL) was observed on POD 15. 
This pattern of elevation is characteristic of daily IL-6 
monitoring. Interestingly, an elevation in TNF-a was also 
observed on POD 12. 
Case 2 
A 48-year-old man with cryptogenic cirrhosis underwent 
orthotopic liver transplantation (Fig 2). His preoperative 
IL-6 level were also high but had normalized about 10 days 
after transplantation. Serum TB levels increased tempo-
rarily after transplantation, possibly due to ischemic injury 
shown by biopsy on POD 5. Serum TB levels normalized on 
POD 20. A biopsy undertaken on POD 21 showed mild 
ACR, and a bolus methylprednisolone (1 g) was adminis-
tered. Serum TB levels did not increase until POD 30. 
Biopsy on POD 29 showed severe ACR and soon after the 
diagnosis, OKT3 monoclonal antibody (10 mgld) was ad-
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Fig 1. A 62-year-old man with 
alcoholic cirrhosis underwent 
liver transplantation. A moder-
ate ACR episode occurred 2 
weeks after transplantation. 
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ministered for 1 week. Eventually. however, the liver graft 
was lost due to other complications. Regarding the dynamic 
changes in IL-6 and TNF-a, as in case 1, an IL-6 spike was 
observed the same day the liver biopsy showed severe 
rejection. It is to be noted that the TNF-a spike appeared 3 
days before the IL-6 spike, as shown in Fig 2. 
Case 3 
A 36-year-old man with alcoholic cirrhosis underwent or-
thotopic liver transplantation (Fig 3). He experienced an 
early-phase moderate AeR, which was proved by liver 
hiopsy on POD 4. On POD 5, an IL-6 spike was observed 
and holus methylprednisolone (I g) was administered. Since 
this rejection was treatment-resistant. OKT3 and steroid 
recycle therapy were tried. Biopsy on POD 19 still showed 
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mild to moderate rejection. Plasma IL-6 levels were high 
and the pattern paralleled that of serum TB level. In this 
case, the TNF-a level was not determined in the earlier 
phase of rejection, but a very high level of TNF-a was 
observed after POD 20. Eventually, the graft was lost. 
Case 4 
A 39-year-old woman with somatostatinoma of the pan-
creas with liver metastasis underwent abdominal organ 
cluster transplantation (Fig 4). As early as POD 5, rejection 
was diagnosed clinically due to a progressive rise in serum 
TB (biopsy not performed) and a methylprednisolone bolus 
and OKT3 was initiated. This regimen was effective, but 
serum TB rose again from POD 11. An IL-6 spike was 
ohserved on POD 12 when steroid and OKT3 therapy was 
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Fig 2. A 48-year-old man With 
cryptogenic CirrhOSIS underwent 
liver transplantation. He experi-
enced severe late-phase ACR 
episodes. 
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restarted. This rejection was confirmed by biopsy subse-
quently on POD 13 indicating moderate ACR. TNF-a 
spikes were observed on POD 4 and 9. TNF-a spike on 
POD 4 is 1 day before the initiation of augmented antire-
jection therapy. 
Case 5 
A 55-year-old man with pancreatic carcinoma and liver 
metastasis underwent abdominal organ cluster transplanta-
tion. The clinical course was complicated by relapsing ACR 
and subsequent sepsis (Fig 5). In this case. the graft was 
eventually lost. In the earlier periods (POD 10 and 20). two 
IL-6 spikes (POD 15 and 19) and one TNF-a spike (POD 
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Fig 4. A 39-year-old woman With pancreatic somatostatinoma 
and liver metastasis underwent abdominal organ cluster trans-
plantation. She experienced moderate AeR. 
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Fig 3. A 36-year-old man with 
alcoholic cirrhosis underwent 
liver transplantation. He had ex-
perienced relapsing ACR epi-
sodes. 
17) were observed. These elevation of cytokines seem very 
closely related to serum TB and biopsy tindings (POD 15: 
moderate ACR, POD 22: mild to moderate ACR, POD 29: 
moderate ACR). 
DISCUSSION 
In this study we have shown that inflammatory cytokines 
(TNF-a. IL-6) are induced in liver allograft rejection. Daily 
monitored serum levels of these cytokines are potentially a 
good premonitor of allograft rejection. 
Liver allograft rejection is characterized by cellular intil-
tration consisting mainly of monocytes/macrophages and 
activated T Iymphocvtes. Inflammatory cytokines such as 
TNF-a and IL-6 arc mainly secretcd bv thcse cells. Kuptfcr 
cells and vascular endothelial cells in the liver may also 
secrete these cytokines. Therefore. both iniiltrating host 
immune cells or cells of the allograft (activated Kuptfer cells 
and endothelial cells) coneeivablv playa role in producing 
these cytokines.-' 
In conventional clinical procedures. liver rejection is tirst 
determined through liver dysfunction. then histologically 
confirmed hy biopsy, after which antirejection therapy is 
started. In this study. we observed spike-shaped TNF-n 
elevation followed hy the elevation of IL-6 (Fig 6). It is well 
known that TNF-a induces I L-6 secretion, so. theoretically. 
TNF-n appears earlier in the bloodstream than IL-6. It is 
also well known that TNF-n is verv ditlicult to detect in thl: 
blood. The five cases we prl:sented all sutfered from <lggres-
,ive rejection. and therefore TNF-n (ould be detected. 
which is unusual under other circumstances. We attempted 
to measure TNF-n ill other cases of rejection. but found it 
impOSSible (data not shown!. 
TNF-n mav also play an important role in rhe path(1phvs-
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Fig 5. A 55-year-old man with 
pancreatic carcinoma and liver 
metastasis underwent abdomi-
nal organ cluster transplanta-
tion. He experienced relapsing 
ACR episodes 2 weeks after 
transplantation. and eventually 
suffered from sepsis and liver 
graft failure. 
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iology of reperfusion injury in liver transplantation. Takei et 
al4 reported that Kupfer cells were activated following cold 
preservation, and inflammatory mediators were released 
from rat liver grafts after reperfusion. Goto et als reported 
that the release of TNF -a by the rat liver graft depended on 
the period of preservation. Thus, the activation of Kupfer 
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Fig 6. Schematic presentation of serum elevation of TNF-" and 
IL-6 in rejection episodes In liver allograft recipients. Usually. 
TNF-n and IL -6 spikes appeared prior to liver dysfunction. 
Clinically. when liver dysfunction appears. liver biopsy IS per-
formed. After histological confirmation. antlrejectlon therapy IS 
Initiated. 
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cells plays an important pathophysiological role in graft 
damage after reperfusion. 
The present results indicate that inflammatory cytokines 
such as TNF-a and IL-6 play an important role in the early 
phase of the rejection episodes. These cytokines are known 
to upregulate the expression of adhesion molecules such as 
ICAM-\. thereby facilitating leukocyte adhesion to sinusoi-
dal endothelium and subsequently causing graft damage 
mainlv due to circulatory failure."·7 As we previously noted, 
the m~re IL-6 spikes demonstrated in recipients. the higher 
the chance of graft loss.2 Therefore. specific inactivation of 
cvtokines or of their actions may prove to he a powerful tool 
i~ the prevention and treatment of allograft rejection and 
graft failure . 
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